Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice

Journal of Clinical Investigation

Volumn 111, Issue 4, 2003, Pages 445-452

  Heximer, Scott P ^a,d   Knutsen, Russell H ^a   Sun, Xiaoguang ^a   Kaltenbronn, Kevin M ^a   Rhee, Man Hee ^a   Peng, Ning ^b   Oliveira dos Santos, Antonio ^c   Penninger, Josef M ^c   Muslin, Anthony J ^a   Steinberg, Thomas H ^a   Wyss, J Michael ^b   Mecham, Robert P ^a   Blumer, Kendall J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c AMGEN INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HORMONE; NEUROTRANSMITTER; PURINE P2Y RECEPTOR; RGS PROTEIN; RGS2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM SIGNALING; CONTROLLED STUDY; GENETIC DISORDER; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RESISTANCE BLOOD VESSEL; RISK FACTOR; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 0037330249     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI15598     Document Type: Article

References (42)

1. Lifton, R.P., Gharavi, A.G., and Geller, D.S. 2001. Molecular mechanisms of human hypertension. Cell. 104:545-556.
2. Takahashi, N., and Smithies, O. 1999. Gene targeting approaches to analyzing hypertension. J. Am. Soc. Nephrol. 10:1598-1605.
3. Asico, L.D., et al. 1998. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J. Clin. Invest. 102:493-498.
4. Berthiaume, N., Yanagisawa, M., Labonte, J., and D'Orleans-Juste, P. 2000. Heterozygous knock-out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse. Hypertension. 36:1002-1007.
5. Kim, H.S., et al. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA. 92:2735-2739.
6. Niranjan, V., Telemaque, S., deWit, D., Gerard, R.D., and Yanagisawa, M. 1996. Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats. J. Clin. Invest. 98:2364-2372.
7. Bengtsson, K., et al. 2001. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation. 104:187-190.
8. Bray, M.S., et al. 2000. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 101:2877-2882.
9. Cockcroft, J.R., et al. 2000. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 36:371-375.
10. Hoit, B.D., Suresh, D.P., Craft, L., Walsh, R.A., and Liggett, S.B. 2000. beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am. Heart J. 139:537-542.
11. Liolitsa, D., Powell,J.F., Prince, M., and Lovestone, S. 2001. Association study of the 5-HT(2A) receptor gene polymorphism, T102C and essential hypertension. J. Hum. Hypertens. 15:335-339.
12. Sierra, C., et al. 2002. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension. Hypertension. 39:343-347.
13. Wang, J.G., and Staessen, J.A. 2000. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur. J. Pharmacol. 410:289-302.
14. Bourne, H.R. 1997. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9:134-142.
15. Ross, E.M., and Wilkie, T.M. 2000. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69:795-827.
16. Ingi, T., et al. 1998. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J. Neurosci. 18:7178-7188.
17. Sinnarajah, S., et al. 2001. RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature. 409:1051-1055.
18. Chen, C., Zheng, B., Han, J., and Lin, S.C. 1997. Characterization of a novel mammalian RGS protein that binds to Galpha proteins and inhibits pheromone signaling in yeast. J. Biol. Chem. 272:8679-8685.
19. Oliveira-Dos-Santos, A.J., et al. 2000. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc. Natl. Acad. Sci. USA. 97:12272-12277.
20. Grant, S.L., et al. 2000. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol. Pharmacol. 57:460-467.
21. Wu, H. K., et al. 1995. Differential expression of a basic helix-loop-helix phosphoprotein gene, GOS8, in acute leukemia and localization to human chromosome 1q31. Leukemia. 9:1291-1298.
22. Mansfield, T.A., et al. 1997. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11.q21. Nat. Genet. 16:202-205.
23. Lorenz, J.N., and Kranias, E.G. 1997. Regulatory effects of phospholamban on cardiac function in intact mice. Am. J. Physiol. 273:H2826-H2831.
24. Mozaffari, M.S., Roysommuti, S., and Wyss, J.M. 1996. Contribution of the sympathetic nervous system to hypertensive response to insulin excess in spontaneously hypertensive rats. J. Candiovasc. Pharmacol. 27:539-544.
25. Rogers,J.H., et al. 1999. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J. Clin. Invest. 104:567-576.
26. Hayashi, K., et al. 1999. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol. 145:727-740.
27. Johns, C., Gavras, I., Handy, D.E., Salomao, A., and Gavras, H. 1996. Models of experimental hypertension in mice. Hypertension. 28:1064-1069.
28. Intengan, H.D., and Schiffrin, E.L. 2001. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 38:581-587.
29. Bivalacqua, T.J., Dalal, A., Champion, H.C., and Kadowitz, P.J. 1999. Role of AT(1) receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice. Am. J. Physiol. 277:E838-E847.
30. Gratton, J.P., et al. 1995. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats. Am. J. Hypertens. 8:1121-1127.
31. Ma, X., Abboud, F.M., and Chapleau, M.W. 2001. A novel effect of angiotensin on renal sympathetic nerve activity in mice. J. Hypertens. 19:609-618.
32. Duka, I., Gavras, I., Johns, C., Handy, D.E., and Gavras, H. 2000. Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in cate catecholamine-induced vasoconstriction. Gen. Pharmacol. 34:101-106.
33. Erlinge, D. 1998. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen. Pharmacol. 31:1-8.
34. Chen, C.K., et al. 2000. Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature. 403:557-560.
35. Eckhart, A.D., Ozaki, T., Tevaearai, H., Rockman, H.A., and Koch, W.J. 2002. Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol. Pharmacol. 61:749-758.
36. Heximer, S.P., Watson, N., Linder, M.E., Blumer, K.J., and Hepler, J.R. 1997. RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc. Natl. Acad. Sci. USA. 94:14389-14393.
37. Heximer, S.P., et al. 1999. G protein selectivity is a determinant of RGS2 function. J Biol. Chem. 274:34253-34259.
38. Ullman, J. 1999. Vasopressin and angiotensin II in blood pressure control during isoflurane anesthesia in rats. Acta Anaesthesiol. Scand. 43:860-865.
39. Saito, S., Hirata, Y., Emori, T., Imai, T., and Marumo, F. 1996. Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors. Hypertens. Res. 19:201-206.
40. Hennington, B.S., Zhang, H., Miller, M.T., Granger, J.P., and Reckelhoff, J.F. 1998. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension. 31:283-288.
41. Pueyo, M.E., Arnal, J.F., Rami, J., and Michel, J.B. 1998. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am. J. Physiol. 274:C214-C220.
42. Tsutsumi, Y., et al. 1999. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104:925-935.